Melvine's AI Analysis # 45 - 🚀 Transforming Pharma: How Eli Lilly is Leveraging AI & Generative AI to Revolutionize Healthcare

Written By melvin manchau

Eli Lilly and Company, a global pharmaceutical leader, has embraced artificial intelligence (AI) and generative AI (Gen AI) to modernize drug discovery and development, streamline manufacturing, and enhance patient-centric solutions. This article explores Eli Lilly's AI initiatives, broader industry trends, competitor strategies, anticipated impacts, and the associated risks, challenges, and regulatory frameworks shaping AI implementation in the pharmaceutical sector.

melvin manchau
Sign up to read this post
Join Now
Previous

Melvine's AI Analysis # 44 -AI in the Lab: How Novartis is Rewriting the Rules of Drug Discovery
Next

Melvine's AI Analysis # 46 - Embracing the Future: AI and Generative AI at Pfizer